Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (321-330 of 664) with videos related to

Pageof 67
Sort By:
Clinical Sarcoma Research|November 21, 2015
Alveolar rhabdomyosarcoma confined to the bone marrow with no identifiable primary tumour using FDG-PET/CTPanagiotis Karagiannis, Nina Guth, Gabriela B Thoennissen, et al.
Oncology Reports|September 24, 2019
DNA methylation of sarcosine dehydrogenase (SARDH) loci as a prognosticator for renal cell carcinomaMehrdad Mazdak, Hossein Tezval, Janne Carmen Callauch, et al.
Plos One|August 29, 2012
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapiesMichael Preukschas, Christian Hagel, Alexander Schulte, et al.
Cancer Biology & Therapy|August 25, 2006
Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinomaDjordje Atanackovic, Inga Blum, Yanran Cao, et al.
BMC Gastroenterology|February 5, 2015
Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancerPhillip Stahl, Carsten Seeschaaf, Patrick Lebok, et al.
Biology|August 6, 2021
Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell DyscrasiasSnjezana Janjetovic, Philipp Lohneis, Axel Nogai, et al.
Health and Quality of Life Outcomes|January 4, 2020
Implementation analysis of patient reported outcomes (PROs) in oncological routine care: an observational study protocolMirja Gianna Görlach, Theresa Schrage, Carsten Bokemeyer, et al.
Journal of Oncology|September 20, 2019
High Aldehyde Dehydrogenase Levels Are Detectable in the Serum of Patients with Lung Cancer and May Be Exploited as Screening BiomarkersAlessandra Rossi, Minna Voigtlaender, Hans Klose, et al.
European Journal of Radiology|April 20, 2005
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residualsAlexander Becherer, Maria De Santis, Georgios Karanikas, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1Paul W Schenk, Hans Stoop, Carsten Bokemeyer, et al.
Pageof 67

Showing results (321-330 of 664) with videos related to

Sort By:
Pageof 67
Clinical Sarcoma Research|November 21, 2015
Alveolar rhabdomyosarcoma confined to the bone marrow with no identifiable primary tumour using FDG-PET/CTPanagiotis Karagiannis, Nina Guth, Gabriela B Thoennissen, et al.
Oncology Reports|September 24, 2019
DNA methylation of sarcosine dehydrogenase (SARDH) loci as a prognosticator for renal cell carcinomaMehrdad Mazdak, Hossein Tezval, Janne Carmen Callauch, et al.
Plos One|August 29, 2012
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapiesMichael Preukschas, Christian Hagel, Alexander Schulte, et al.
Cancer Biology & Therapy|August 25, 2006
Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinomaDjordje Atanackovic, Inga Blum, Yanran Cao, et al.
BMC Gastroenterology|February 5, 2015
Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancerPhillip Stahl, Carsten Seeschaaf, Patrick Lebok, et al.
Biology|August 6, 2021
Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell DyscrasiasSnjezana Janjetovic, Philipp Lohneis, Axel Nogai, et al.
Health and Quality of Life Outcomes|January 4, 2020
Implementation analysis of patient reported outcomes (PROs) in oncological routine care: an observational study protocolMirja Gianna Görlach, Theresa Schrage, Carsten Bokemeyer, et al.
Journal of Oncology|September 20, 2019
High Aldehyde Dehydrogenase Levels Are Detectable in the Serum of Patients with Lung Cancer and May Be Exploited as Screening BiomarkersAlessandra Rossi, Minna Voigtlaender, Hans Klose, et al.
European Journal of Radiology|April 20, 2005
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residualsAlexander Becherer, Maria De Santis, Georgios Karanikas, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1Paul W Schenk, Hans Stoop, Carsten Bokemeyer, et al.
Pageof 67